Effects of cognitive behavioral therapy on sleep quality and insomnia severity index in women with menopausal insomnia: a systematic review and meta-analysis.
Hee-Jin Moon, Se-Na Yu, Myung-Haeng Hur
PMID 41531400WHAT IT FOUND
Cognitive behavioral therapy for insomnia significantly improved sleep quality and reduced insomnia severity in menopausal women.
Remote delivery was as effective as face-to-face sessions, and benefits persisted for more than 25 weeks after treatment ended.
Key findings
01CBT-I produced a statistically significant improvement in sleep quality (SMD -1.01) and a mean reduction of 4.49 points in insomnia severity scores.
02There was no significant difference in effectiveness between face-to-face and remotely delivered CBT-I for either sleep quality or insomnia severity.
03Improvements in sleep quality and insomnia severity remained significant when assessed more than 25 weeks after the intervention ended.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
High heterogeneity (I²=89%) in the insomnia severity analysis suggests considerable variation in study designs and populations. Three studies were rated as having a high risk of bias due to missing outcome data. Approximately half of the studies were conducted in the United States, which may limit the generalizability of findings to other cultural contexts regarding menopause and sleep perceptions. The review excluded studies where pharmacological interventions were added to the treatment, so it does not address CBT-I efficacy in combination with new sleep medications.
Declared interests
The authors declared no conflicts of interest and received no funding.
The easy way to misread this
Do not assume CBT-I works for all menopausal insomnia cases. The review excluded studies where participants received additional pharmacological interventions beyond their usual medications, so the effect size reported here applies to CBT-I used alone or with routine care, not necessarily in complex cases requiring concurrent new drug therapy.